CareTrust REIT is a self-administered, publicly-traded real estate investment trust engaged in the ownership, acquisition, development and leasing of seniors housing and healthcare-related properties. CareTrust REIT generates revenues primarily by leasing properties to a diverse group of local, regional and national seniors housing operators, healthcare services providers, and other healthcare-related businesses. Since its debut as a standalone public company on June 1, 2014, and as of March 31, 2025, CareTrust REIT has expanded its tenant roster to 26 operators, and has grown its real estate portfolio to 249 net-leased healthcare properties across 32 states, consisting of 27,229 operating beds/units, excluding 6 properties classified as held for sale as of March 31, 2025. As of March 31, 2025, CareTrust REIT also had 21 other real estate related investments related to 113 healthcare properties across 17 states, consisting of 11,968 operating beds/units and one financing receivable related to 46 properties in one state consisting of 3,820 operating beds/units.
Financial Resilience | CareTrust REIT showcases robust financial health with impressive revenue growth, strong profit margins, and a solid balance sheet, positioning it for sustained growth |
Acquisition Prowess | Explore CareTrust's strategic acquisition pipeline and its impact on FFO growth projections, highlighting the company's aggressive expansion in the healthcare real estate secto |
Market Valuation | With a 31% YTD stock price increase, CareTrust trades at a premium. Analysts offer diverse perspectives, with price targets ranging from $31 to $34 |
Tenant Concentration | Delve into the potential risks associated with CareTrust's reliance on key tenants, particularly PACS, and how it may affect future growth strategies and market perception |
Metrics to compare | CTRE | Sector Sector - Average of metrics from a broad group of related Real Estate sector companies | Relationship RelationshipCTREPeersSector | |
---|---|---|---|---|
P/E Ratio | 33.3x | 47.2x | 8.5x | |
PEG Ratio | 0.46 | 0.26 | 0.01 | |
Price/Book | 1.8x | 1.6x | 0.9x | |
Price / LTM Sales | 16.3x | 4.8x | 3.7x | |
Upside (Analyst Target) | 14.1% | 18.0% | 16.7% | |
Fair Value Upside | Unlock | 7.0% | 2.7% | Unlock |